Fineotex Chemical Limited — Others, 12-08-2025: Appointment

Fineotex Chemical's board approved financial results for the quarter ended June 30, 2025. Consolidated revenue rose 14.43% to ₹137.07 Cr, PAT increased 24.34% to ₹25.03 Cr, and EBITDA grew 18.37% to ₹25.20 Cr. Volume growth was 14.73% with ROIC at 30.72%. A new 3,00,000 sq. ft. manufacturing facility at Ambernath commenced commercial production. The 22nd Annual General Meeting is set for September 19. Appointments of a Secretarial Auditor and Independent Director were approved, pending shareholder consent. Additionally, 58,797 stock options were granted to employees.